Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Malaria Vaccine

  • Broadcast in Health
African Views

African Views


Follow This Show

If you liked this show, you should follow African Views.
According to the World Health Organization,the African Region accounts for 85% of malaria cases and 90% of malaria deaths worldwide. 85% of malaria deaths occur in children under five years of age. Every 30 seconds a child dies from malaria. The disease cause huge economic losses.

The discovery of malaria vaccine can significantly reverse these disheartening figures. Malaria vaccines are considered amongst the most important modalities for potential prevention of malaria disease and death. Research and development in this field has been an area of intense effort by many groups over the last few decades. Despite this, there is currently no licensed, effective malaria vaccine. Researchers, clinical trialists and vaccine developers have been working on many approaches to bring forward the availability of such a highly effective malaria vaccine.

The most notable effort is by The PATH Malaria Vaccine Initiative (MVI), a global program of the international nonprofit organization PATH. MVI was established in 1999 through a grant from the Bill & Melinda Gates Foundation. Its to accelerate the development of malaria vaccines and ensure their availability and accessibility in the developing world. It sees a a world free from malaria.

This week, we shall look at the social and economic implications of malaria in Africa, available preventive measures and recent findings on malaria vaccines.